117 related articles for article (PubMed ID: 38521176)
1. Synthesis and antihepatoma activity of guaianolide dimers derived from lavandiolide I.
Wang X; Li TZ; Ma YB; Ma WJ; Xue D; Chen JJ
Bioorg Med Chem Lett; 2024 May; 104():129708. PubMed ID: 38521176
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of guaianolide-germacranolide heterodimers as novel anticancer agents against hepatocellular carcinoma.
Yan JX; Li QH; Li TZ; Huang ZY; Ma YB; Chen JJ
Drug Dev Res; 2023 Sep; 84(6):1285-1298. PubMed ID: 37345274
[TBL] [Abstract][Full Text] [Related]
3. Artemongolins A-K, undescribed germacrane-guaiane sesquiterpenoid dimers from Artemisia mongolica and their antihepatoma activities.
Shang C; Ma YB; Wang Y; He XF; Li TZ; Chen JJ
Arch Pharm Res; 2023 Oct; 46(9-10):782-794. PubMed ID: 37770811
[TBL] [Abstract][Full Text] [Related]
4. Artemidubolides A-T, cytotoxic unreported guaiane-type sesquiterpenoid dimers against three hepatoma cell lines from Artemisia dubia.
Gao Z; Ma WJ; Li TZ; Ma YB; Hu J; Huang XY; Geng CA; He XF; Zhang XM; Chen JJ
Phytochemistry; 2022 Oct; 202():113299. PubMed ID: 35809862
[TBL] [Abstract][Full Text] [Related]
5. Artemyriantholides A-K, guaiane-type sesquiterpenoid dimers from Artemisia myriantha var. pleiocephala and their antihepatoma activity.
Wang MF; Li TZ; Ma YB; Ma WJ; Wang YC; Li FJ; Chen JJ
Phytochemistry; 2024 Jun; 222():114100. PubMed ID: 38636688
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of artemyrianolide H derivatives as potential antihepatoma agents.
Li TZ; Yang XT; Ma WJ; Ma YB; Li FJ; Wang YC; Chen JJ
Bioorg Chem; 2023 Aug; 137():106617. PubMed ID: 37267793
[TBL] [Abstract][Full Text] [Related]
7. Highly oxygenated guaiane-type sesquiterpene lactones from Artemisia sacrorum and their antihepatoma activity.
He XF; Ma YB; Li TZ; Chen JJ
Phytochemistry; 2024 Jan; 217():113930. PubMed ID: 37993076
[TBL] [Abstract][Full Text] [Related]
8. Artemiprinolides A-M, thirteen undescribed sesquiterpenoid dimers from Artemisia princeps and their antihepatoma activity.
Su LH; Ma WJ; Ma YB; Li TZ; Geng CA; Dong W; He XF; Chen JJ
Phytochemistry; 2023 Jul; 211():113714. PubMed ID: 37156434
[TBL] [Abstract][Full Text] [Related]
9. Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans.
Hu YX; Liu Z; Zhang Z; Deng Z; Huang Z; Feng T; Zhou QH; Mei S; Yi C; Zhou Q; Zeng PH; Pei G; Tian S; Tian XF
World J Gastroenterol; 2023 Mar; 29(12):1875-1898. PubMed ID: 37032730
[TBL] [Abstract][Full Text] [Related]
10. New guaiane-type sesquiterpenoid dimers from
Su L; Zhang X; Ma Y; Geng C; Huang X; Hu J; Li T; Tang S; Shen C; Gao Z; Zhang X; Chen JJ
Acta Pharm Sin B; 2021 Jun; 11(6):1648-1666. PubMed ID: 34221874
[TBL] [Abstract][Full Text] [Related]
11. The application of Heck reaction in the synthesis of guaianolide sesquiterpene lactones derivatives selectively inhibiting resistant acute leukemic cells.
Ding YH; Fan HX; Long J; Zhang Q; Chen Y
Bioorg Med Chem Lett; 2013 Nov; 23(22):6087-92. PubMed ID: 24095093
[TBL] [Abstract][Full Text] [Related]
12. Artemdubinoids A-N: novel sesquiterpenoids with antihepatoma cytotoxicity from Artemisia dubia.
Gao Z; Li T; Ma Y; Huang X; Geng C; Zhang X; Chen J
Chin J Nat Med; 2023 Dec; 21(12):902-915. PubMed ID: 38143104
[TBL] [Abstract][Full Text] [Related]
13. Artematrovirenins A-P, guaiane-type sesquiterpenoids with cytotoxicities against two hepatoma cell lines from Artemisia atrovirens.
Su LH; Ma YB; Geng CA; Li TZ; Huang XY; Hu J; Xin Zhang ; Tang S; Shen C; Gao Z; Zhang XM; Chen JJ
Bioorg Chem; 2021 Sep; 114():105072. PubMed ID: 34144276
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Characterization and Anti-hepatoma Activity of New Hederagenin Derivatives.
Liu X; Sun L; Liu QH; Chen BQ; Liu YM
Mini Rev Med Chem; 2020; 20(3):252-257. PubMed ID: 32134368
[TBL] [Abstract][Full Text] [Related]
15. A Novel Method to Synthesize 4-Aryl-1H-1,2,3-Triazoles and its Antihepatoma Activity.
Li X; He Y; Hai L; Zhang T; Wu Y
Anticancer Agents Med Chem; 2016; 16(12):1622-1627. PubMed ID: 26592747
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, biological evaluation, and modeling studies of novel conformationally-restricted analogues of sorafenib as selective kinase-inhibitory antiproliferative agents against hepatocellular carcinoma cells.
Sbenati RM; Zaraei SO; El-Gamal MI; Anbar HS; Tarazi H; Zoghbor MM; Mohamood NA; Khakpour MM; Zaher DM; Omar HA; Alach NN; Shehata MK; El-Gamal R
Eur J Med Chem; 2021 Jan; 210():113081. PubMed ID: 33310290
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of ludartin derivatives as potential anticancer agents against hepatocellular carcinoma.
Sun JJ; Wang JP; Li TZ; Ma YB; Xue D; Chen JJ
Med Chem Res; 2022; 31(7):1224-1239. PubMed ID: 35634434
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, anticancer, and docking of some S- and/or N-heterocyclic derivatives as VEGFR-2 inhibitors.
El-Adl K; Abdel-Rahman AA; Omar AM; Alswah M; Saleh NM
Arch Pharm (Weinheim); 2022 Feb; 355(2):e2100237. PubMed ID: 34862655
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of novel 7-ethyl-10-fluoro-20-O-(cinnamic acid ester)-camptothecin derivatives as potential high selectivity and low toxicity topoisomerase I inhibitors for hepatocellular carcinoma.
Bai YP; Yang CJ; Deng N; Zhang M; Zhang ZJ; Li L; Zhou Y; Luo XF; Xu CR; Zhang BQ; Ma Y; Liu YQ
Biochem Pharmacol; 2022 Jun; 200():115049. PubMed ID: 35469784
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis and biological evaluation of (-)-englerin A and B: synthesis of analogues with improved activity profile.
Radtke L; Willot M; Sun H; Ziegler S; Sauerland S; Strohmann C; Fröhlich R; Habenberger P; Waldmann H; Christmann M
Angew Chem Int Ed Engl; 2011 Apr; 50(17):3998-4002. PubMed ID: 21472928
[No Abstract] [Full Text] [Related]
[Next] [New Search]
